Hostname: page-component-8448b6f56d-42gr6 Total loading time: 0 Render date: 2024-04-23T09:01:13.276Z Has data issue: false hasContentIssue false
  • English
  • Français

A study of the prescribing of psychotropic drugs in a Dublin psychiatric hospital

Published online by Cambridge University Press:  13 June 2014

Denis J Murphy ,
Miriam A. Gannon ,
Declan Fitzpatrick ,
Rajendar Kumar ,
Harry Doyle ,
James H O'Boyle  and
Aidan McGennis
Denis J Murphy
Affiliation:
Senior Registrar in Psychiatry
Harry Doyle
Affiliation:
Psychiatric Registrars
Aidan McGennis
Affiliation:
Consultant Psychiatrists
Get access Rights & Permissions [Opens in a new window]

Abstract

To date there has been no study of prescribing habits in a psychiatric hospital in Ireland, as has happened elsewhere.

In a survey over one weekend at St. Brendan's Hospital, the prescription sheets and case notes of all 772 patients were examined.

The principal findings were polypharmacy, the use of benzodiazepines for disturbingly long periods of time, the preponderant prescription of drugs by their proprietary names and the extensive use of neuroleptics for apparently non-psychotic conditions. These results are discussed in the light of other similar surveys.

Keywords

Prescriptionpsychotropic drugspsychiatric hospitalpolypharmacyneurolepticsantidepressantsbenzodiazepinesgeneric namesproprietary names
Type
Original Papers
Information
Irish Journal of Psychological Medicine , Volume 7 , Issue 1 , March 1990 , pp. 26 - 31
Copyright
Copyright © Cambridge University Press 1990

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Tyrer, P. Drug treatment of psychiatric patients in general practice. Br Med J 1978; 2: 1008–1010.CrossRefGoogle ScholarPubMed
2.Michel, K, Kolakowska, T. A survey of psychotropic drug prescribing in two psychiatric hospital. Br J Psychiatry 1981; 138: 217–221.CrossRefGoogle Scholar
3.James, DH. Monitoring drugs in hospitals for the mentally handicapped. Br J Psychiatry 1983; 142: 163–165.CrossRefGoogle ScholarPubMed
4.Sheppard, C, Collins, L, Fiorentino, D, et al.Polypharmacy in psychiatric treatment: I. Incidence at a state hospital. Current Therapeutic Research 1969; 11: 765–774.Google ScholarPubMed
5.Diamond, H, Tislow, R, Snyder, T, et al.Peer review of prescribing patterns in a C.M.H.C. Am J Psychiatry 1976; 133: 697–699.Google Scholar
6.Edwards, S, Kumar, V. A survey of prescribing of psychotropic drugs in a Birmingham psychiatric hospital. Br J Psychiatry 1984; 145: 502–507.CrossRefGoogle Scholar
7.Morgan, R, Gopalaswamy, AK. Psychotropic drugs: another survey of prescribing habits. Br J Psychiatry 1984; 144: 298–302.CrossRefGoogle Scholar
8.Yosselson-Superstine, S, Sternik, D, Liebenzon, D. Prescribing patters in psychiatric hospital in Israel. Acta Psychiatr Scand 1979; 60: 477–482.CrossRefGoogle Scholar
9.Hemminki, E. Polypharmacy among psychiatric patients. Acta Psychiatr Scand 1977; 56: 347–356.CrossRefGoogle ScholarPubMed
10.British Medical Association and Pharmaceutical Society of Great Britain. British National Formulary Number 17. London, 1989.Google Scholar
11.SAS Institute Incorporated. Statistical Analysis System. Cary NC: SAS Institute Inc, 1986.Google Scholar
12.Laska, E, Varga, E, Wanderling, Jet al.Patterns of psychotropic drug use for schizophrenia. Diseases of the Nervous System 1973; 34: 294–305.Google ScholarPubMed
13.Clark, AF, Holden, NL. The persistence of prescribing habits: a survey and follow-up of prescribing to chronic hospital inpatients. Br J Psychiatry 1987; 150: 88–91.CrossRefGoogle Scholar
14.Muijen, M, Silverstone, T. A comparative hospital survey of psychotropic drug prescribing. Br J Psychiatry 1984; 144: 298–302.Google Scholar
15.Avd, FJ. Rational pharmacotherapy: once a day drug dosage. Diseases of the Nervous System 1973; 34: 371–378.Google Scholar
16.Youssef, HA. Haloperidol decanoate in place of multiple drug therapy in chronic schizophrenia patients. Acta Therapeutica 1983; 9: 215–225.Google Scholar
17.Leonard, BE. Biochemical aspects of therapy-resistant depression. Br J Psychiatry 1988; 152: 453–459.CrossRefGoogle ScholarPubMed
18.Akiskal, HS. A proposed approach to chronic and resistant depression: evaluation and treatment. J Clin Psychiatry 1985; 46: 32–36.Google ScholarPubMed
19.Anderson, DN. A comparison of inpatient and outpatient prescribing. Br J Psychiatry 1989; 154: 644–649.CrossRefGoogle Scholar
20.Powell, BJ, Othmer, E, Senkorn, C. Pharmacological aftercare for homogeneous groups of patients. Hosp Community Psychiatry 1977; 28: 125–7.Google ScholarPubMed
21.Youssef, FA. Compliance with therapeutic regimes: a follow up study for patients with affective disorders. J Adv Nurs 1983; 8: 513–517.CrossRefGoogle Scholar
22.Mason, AS, Forrest, IS, Forrest, FM, Butler, H. Adherence to maintenance therapy and rehospitalisation. Diseases of the Nervous System 1963; 24: 103–104.Google Scholar
23.Petursson, H, Lader, MH. Withdrawal from long term benzodiazepine treatment. B Med J 1981; 283: 643–645.CrossRefGoogle ScholarPubMed
24. Editorial. For and against generic prescribing. Drug Ther Bull 1987; 25: 93–95.CrossRefGoogle Scholar
25.Feely, J. Generic prescribing – can we achieve a balance? Ir Med J 1986; 79: 241–242.Google ScholarPubMed